GNH USA

Europe — EMA

Lamivudin/Zidovudin Heumann

GNH USA supplies Lamivudin/Zidovudin Heumann (Lamivudine/Zidovudine), a nucleoside reverse transcriptase inhibitor for HIV infection. Request a quote today.

Zidovudine, Lamivudine

Request sourcing

1
Pack/s

What is Zidovudine, Lamivudine?

Lamivudin/Zidovudin, the active ingredient in Lamivudin/Zidovudin Heumann, is a Nucleoside reverse transcriptase inhibitor (NRTI) presented as a strength/form not specified for oral use. It is used to treat Human Immunodeficiency Virus (HIV) infection in adults and children.

GNH USA supplies Lamivudin/Zidovudin Heumann as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent product availability and regulatory compliance across European and other markets.

What is Zidovudine, Lamivudine used for?

Lamivudin/Zidovudin is used as part of antiretroviral therapy targeting HIV replication.

Human Immunodeficiency Virus (HIV) infection: reduces viral load and helps restore immune function AIDS-related opportunistic infections: used in combination regimens to control HIV and prevent disease progression Pregnant women with HIV: included in treatment plans to lower the risk of mother‑to‑child transmission

What are the side effects of Zidovudine, Lamivudine?

Lamivudin/Zidovudin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Headache - Fatigue - Anemia - Neutropenia - Diarrhea

Serious or Rare Side Effects: - Lactic acidosis - Severe hepatotoxicity - Bone marrow suppression - Hypersensitivity reactions - Pancreatitis - Severe anemia

What precautions apply to Zidovudine, Lamivudine?

Before initiating therapy, clinicians should evaluate patient-specific factors and monitor for potential complications.

Renal function: assess baseline kidney function and monitor during therapy Hepatic function: evaluate liver enzymes before initiating treatment Hematologic status: monitor complete blood count for anemia or neutropenia Pregnancy: weigh benefits against potential risks and consult specialist Drug resistance: avoid monotherapy to prevent development of resistant HIV strains Store at ambient temperature: keep below 25 °C, protect from moisture and light in original container

What does Zidovudine, Lamivudine interact with?

Lamivudin/Zidovudin can interact with several other medicines, requiring careful management.

Major Interactions (Avoid): - Didanosine: concurrent use increases risk of severe peripheral neuropathy and pancreatitis - Stavudine: combined use may exacerbate mitochondrial toxicity - Alcohol: may heighten risk of liver toxicity

Moderate Interactions (Monitor Closely): - Protease inhibitors: may increase plasma levels of zidovudine - Non‑nucleoside reverse transcriptase inhibitors: may affect lamivudine metabolism - Anticoagulants: monitor INR as zidovudine can potentiate effects

Frequently asked questions

What is Lamivudin/Zidovudin Heumann used for?+
Lamivudin/Zidovudin Heumann is an antiretroviral medication indicated for the treatment of Human Immunodeficiency Virus (HIV) infection. It is used as part of combination therapy to lower viral load, improve immune function, and reduce the risk of disease progression in both adults and children.
How does Lamivudin/Zidovudin work?+
Both lamivudin and zidovudine are nucleoside reverse transcriptase inhibitors. After oral absorption, they are phosphorylated inside cells to active triphosphate forms that compete with natural nucleosides. Incorporation of these analogues into viral DNA halts chain elongation, thereby blocking HIV reverse transcription and replication.
What is the usual dose of Lamivudin/Zidovudin?+
The dosage of Lamivudin/Zidovudin is individualized and must be prescribed by a qualified healthcare professional. The prescriber determines the exact amount, frequency, and duration based on the patient’s age, weight, renal and hepatic function, and overall treatment regimen.
Is Lamivudin/Zidovudin safe during pregnancy or breastfeeding?+
Safety in pregnancy and lactation has not been fully established. Clinicians should weigh the potential benefits for the mother against any possible risks to the fetus or infant. When treatment is essential, it may be continued under close medical supervision, and breastfeeding decisions should follow local guidelines.
How do I order Lamivudin/Zidovudin from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Lamivudin/Zidovudin compare with other antiretroviral options?+
Lamivudin/Zidovudin belongs to the NRTI class and is often compared with other fixed‑dose combinations such as tenofovir/emtricitabine. While all provide backbone therapy, the choice depends on factors like resistance profile, renal function, tolerability, and patient‑specific considerations. Lamivudin/Zidovudin has a long safety record but may have higher rates of anemia compared with some newer agents.
What are the storage and handling requirements for Lamivudin/Zidovudin?+
The product should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children. Do not store in humid or excessively hot environments.
How is Lamivudin/Zidovudin administered?+
Lamivudin/Zidovudin is taken orally, usually as a tablet. Patients should swallow the tablet whole with a glass of water, preferably with food to reduce gastrointestinal upset. The exact schedule—once or twice daily—depends on the prescribing clinician’s regimen.
What are the most serious risks associated with Lamivudin/Zidovudin?+
Serious adverse events include lactic acidosis, severe hepatotoxicity, bone‑marrow suppression leading to profound anemia or neutropenia, and hypersensitivity reactions such as Stevens‑Johnson syndrome. Patients should be instructed to seek immediate medical attention if they experience unexplained fatigue, abdominal pain, rapid breathing, or skin rash.
Who should not use Lamivudin/Zidovudin?+
Lamivudin/Zidovudin is contraindicated in individuals with known hypersensitivity to lamivudin, zidovudine, or any excipients in the formulation. Caution is advised for patients with severe hepatic impairment, pre‑existing bone‑marrow disorders, or active opportunistic infections that require alternative therapy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Zidovudine, Lamivudine
Route
Oral Use
Manufacturer
Heumann Pharma Gmbh & Co. Generica Kg
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU